Mitochondrial Antioxidant Therapy to Resolve Inflammation in Ulcerative Colitis
A good week for study, we recruited 4 (!) patients into MARVEL inc 1st patient in #Manchester thanks to Pro Limdi's wonderful team. Mitochondrial antioxidants in UC www.marvelstudy.uk. Novel ways to treat IBD. #ibd #ulcerativecolitis #mitochondria
— Glasgow Gut Science (@glasgowgutscience.bsky.social) 14 February 2025 at 08:22
[image or embed]
We're making good progress in our MARVEL IBD trial www.marvelstudy.uk oral mitochondrial antioxidants in Ulcerative Colitis. Thus week our fab team in #Glasgow recruited a further 2 patients, nearly n=60 (target 200). 😀 #ibd #Colitis #mitochondria #trials
— Glasgow Gut Science (@glasgowgutscience.bsky.social) 7 February 2025 at 16:37
[image or embed]
Marvel Study Overview
Introducing MARVEL
By Lisa Derr, Trial Manager
Marvel Recruitment Status
Center Breakdown
I'm delighted to take forward the research findings over the last 10 years from my scientific team into a human clinical trial. This has been a journey involving many scientists, clinicians and also our patients. The MARVEL study will provide very much needed data to show whether this new treatment approach will work in Ulcerative Colitis.
DR GWO-TZER HO
Chief Investigator
Centre for Inflammation Research
University of Edinburgh
Sponsors
About Us
Centre for Inflammation Research, Queen's Medical Research Institute
Edinburgh BioQuarter Site OverviewDr Gwo-Tzer Ho
Chief Investigator (Marvel)
Professor David Wilson
Chief Investigator (mini-Marvel)
Professor Chris Probert
Chair, Trial Steering Committee
Professor Jonathan Rhodes
Chair, Data Monitoring Committee
Michelle Wilson
Research Associate
Dr Rebecca Hall
Clinical Research Fellow
Dr Shaun Chuah
Clinical Research Fellow
Beena Pouloose
Clinical Research Nurse
Athena Oddy
Clinical Research Nurse
Alix MacDonald
Trial Manager
Lisa Derr
Trial Manager
Katherine Lewis
Trial Support Officer